Pharma Welcomes UK Incentive Plan To Tackle AMR

There has been an enthusiastic response from industry to the news that NICE and NHS England are to explore a new payment model that pays pharmaceutical companies based on how valuable their medicines are to the country's health service, rather than on the quantity of antibiotics sold.

PillsGBP
UK to pursue new payment model for antibiotics • Source: Shutterstock

The pharmaceutical industry says it is ready to play its part in meeting the challenge of antimicrobial resistance (AMR) after being buoyed by the UK government's launch of a major proposal that could offer drug makers a new payment model and incentivize more research in the area.

The government has published a 20-year vision and five-year national action plan for how the UK will contribute to containing...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anti-infective

More from Therapeutic Category